FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
9.49
0.01 (0.11%)
At close: Aug 15, 2025, 3:59 PM
9.44
-0.58%
After-hours: Aug 15, 2025, 07:24 PM EDT

FibroGen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-47.58M -284.23M -293.65M -290.02M
Depreciation & Amortization
2.69M 9.93M 10.6M 14.81M
Stock-Based Compensation
25.21M 50.77M 65.6M 71.16M
Other Working Capital
-147.52M -105.91M 74.75M 48.26M
Other Non-Cash Items
-868K 28.2M 1.09M 61.74M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-117.46M -119.69M 70.43M 60.08M
Operating Cash Flow
-138M -315.02M -145.93M -82.23M
Capital Expenditures
-266K -2.52M -38.74M -30.19M
Cash Acquisitions
1.05M 656K n/a n/a
Purchase of Investments
-8.63M -251.83M -164.02M -484.14M
Sales Maturities Of Investments
133.84M 407.35M 291.87M 87.36M
Other Investing Acitivies
n/a n/a -34.99M -25M
Investing Cash Flow
125.99M 153.66M 89.12M -426.97M
Debt Repayment
-40K 73.59M -538K -5.89M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-2.23M n/a n/a n/a
Other Financial Acitivies
1.88M 748K 43.13M -7.37M
Financial Cash Flow
-255K 122.75M 46.78M -563K
Net Cash Flow
-11.51M -42.01M -15.52M -507.17M
Free Cash Flow
-138.26M -317.54M -184.67M -112.42M